Effects of free and liposomal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans
- 1 February 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (2) , 152-155
- https://doi.org/10.1128/aac.33.2.152
Abstract
We studied the toxic effects of amphotericin B and gramicidin S, alone and in combination, using free and liposome-encapsulated drugs. In vitro toxic effects of the drugs on human erythrocytes and Candida albicans were determined by measuring leakage of intracellular potassium ions (K+). Liposomal formulations of both drugs greatly reduced K+ leakage from human erythrocytes, whereas liposomal gramicidin S, but not liposomal amphotericin B, prevented K+ leakage from C. albicans. In both free and liposomal forms, the combinations of drugs produced decreased toxicity to erythrocytes compared with the drugs alone. This protective effect was more apparent with liposomal combinations than with free drug combinations. A significant increase in fungal cell toxicity was observed, however, when free and liposomal drug combinations were tested against C. albicans. The results suggest that optimal concentrations of liposomal drug combinations (amphotericin B and gramicidin S) may provide increased toxicity against fungal cells and simultaneously protect mammalian cells.This publication has 10 references indexed in Scilit:
- Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NFAntimicrobial Agents and Chemotherapy, 1987
- Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicansAntimicrobial Agents and Chemotherapy, 1987
- Prophylaxis of murine candidiasis via application of liposome-encapsulated amphotericin B and a muramyl dipeptide analog, alone and in combinationAntimicrobial Agents and Chemotherapy, 1985
- Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary StudyThe Journal of Infectious Diseases, 1985
- Liposomal amphotericin B is toxic to fungal cells but not to mammalian cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984
- In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin BAntimicrobial Agents and Chemotherapy, 1984
- Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin BThe Journal of Infectious Diseases, 1983
- Antifungal Action of Amphotericin B in Combination with Other Polyene or Imidazole AntibioticsThe Journal of Infectious Diseases, 1982
- Classification of Polyene Antibiotics According to Chemical Structure and Biological EffectsAntimicrobial Agents and Chemotherapy, 1979
- The Release of Potassium Ions from Candida albicans in the Presence of Polyene AntibioticsJournal of General Microbiology, 1974